Akero Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $336k | 14k | 23.38 |
| 2023-09-30 | $2.3M | 46k | 50.58 |
| 2023-06-30 | $2.3M | 49k | 46.69 |
| 2022-12-31 | $100k | 1.8k | 54.80 |
| 2022-09-30 | $1.6M | 44k | 35.09 |
| 2022-06-30 | $17k | 1.8k | 9.66 |
| 2022-03-31 | $58k | 4.1k | 14.20 |
| 2021-12-31 | $274k | 13k | 21.13 |
| 2021-09-30 | $18k | 477 | 37.04 |
| 2021-06-30 | $8.4k | 227 | 37.04 |
| 2021-03-31 | $11k | 377 | 28.57 |
| 2020-12-31 | $775k | 30k | 25.80 |
| 2020-09-30 | $189k | 6.4k | 29.54 |
| 2020-06-30 | $532k | 21k | 24.92 |
| 2020-03-31 | $130k | 6.1k | 21.16 |
| 2019-12-31 | $70k | 3.2k | 22.02 |
| 2019-09-30 | $9.0k | 386 | 23.32 |